KATHLEEN PARMA: Open Payments
NPI 1457540585 · VICTORIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 30 payments from 11 companies in 2025. Trend: 2023 $1,087 · 2024 $766 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $260 |
| Novo Nordisk Inc | 4 | $84 |
| Amgen Inc. | 2 | $40 |
| PFIZER INC. | 2 | $39 |
| Corium, LLC | 1 | $26 |
| Exact Sciences Corporation | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
Products named: VRAYLAR, QULIPTA, Wegovy, OTEZLA, Azstarys, Cologuard Collection Kit, NURTEC ODT, Ozempic.
Industry payments across TX — which companies pay providers there.
